Equibles does not estimate personal net worth.
Get an email with a short summary when Sagimet Biosciences Inc. publishes a filing, an earnings call transcript or a press release.
Get SGMT alertsThe proxy statement of Corcept Therapeutics Inc reports total compensation of $2,063,274 for Andreas Grauer in fiscal 2020, including a base salary of $454,550. Disclosed compensation is on record for 2 fiscal years. Andreas Grauer has spoken on 1 investor event across 1 company, most recently for Sagimet Biosciences Inc. on August 11, 2026. Sagimet Biosciences Inc. is classified in the Biotechnology industry within the Healthcare sector. Omeros Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sagimet Biosciences Inc. includes David Happel (CEO and Board Member), George Kemble (Chairman and Board Member), Anthony Rimac (CFO and Chief Accounting Officer) and 7 others.
“Yeah, so the phase 3 study that our partners in China have performed And Esclatus is a study that they randomized 480 patients one-to-one. These patients had moderate to severe acne.”
Proxy statement
Start not stated–present
Last confirmed April 21, 2026
Source not stated
Proxy statement
Start not stated–2021-04-22
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Corcept Therapeutics Inc (CORT) | M.D., Chief Medical Officer | $454,550 | $2,063,274 |
| 2019 | Corcept Therapeutics Inc (CORT) | M.D., Chief Medical Officer | $362,267 | $3,799,567 |
